Through working with OpenAI, Massive Bio converts complex clinical trial criteria into machine-readable formats.

Technology Adoption Program (TAP) program success demonstrates the ability of Cellares’ IDMO Smart Factory to automate, lower costs and scale out manufacturing for Cabaletta Bio’s clinical-stage CAR T ...

Cellares, an Integrated Development and Manufacturing Organization (IDMO), concluded the Technology Adoption Program (TAP) on its automated cell therapy manufacturing Cell Shuttle™ for resecabtagene ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Aqua Bio Technology ASA’s subsidiary, ...

PARIS — Spore.Bio has raised $23 million in a Series A funding, led by European venture capital firm Singular, bringing its total funding to $31.3 million. Spore.Bio is a technology startup that ...

Wearable Devices expands its AI-powered LMM technology into predictive health monitoring and cognitive state analytics, enhancing real-time health insights. Wearable Devices Ltd., a technology company ...

A Frederick biotech company will unveil a new technology allowing cellular-level observation of tumors at a conference in Philadelphia next week. Nanocrine, based in the headquarters for the Frederick ...

Takara Bio USA, Inc. today announced a benchmark study comparing the performance of its Trekker® FX technology against ...

The United Bio-Technology (Hengqin) Co. Ltd. has reported compounds acting as glucagon-like peptide 1 receptor (GLP-1R) agonists. They are reported to be useful for the treatment of diabetes type 1, ...